Ghrelin
You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.
| Ghrelin/obestatin preprohormone
| ||||||||||||||
| Identifiers | ||||||||||||||
| Symbol(s) | GHRL; MTLRP; ghrelin; obestatin | |||||||||||||
| External IDs | OMIM: 605353 MGI: 1930008 Homologene: 9487 | |||||||||||||
| ||||||||||||||
| Orthologs | ||||||||||||||
| Human | Mouse | |||||||||||||
| Entrez | 51738 | 58991 | ||||||||||||
| Ensembl | ENSG00000157017 | ENSMUSG00000064177 | ||||||||||||
| Uniprot | Q9UBU3 | Q9EQX0 | ||||||||||||
| Refseq | NM_016362 (mRNA) NP_057446 (protein) | NM_021488 (mRNA) NP_067463 (protein) | ||||||||||||
| Location | Chr 3: 10.3 - 10.31 Mb | Chr 6: 113.68 - 113.69 Mb | ||||||||||||
| Pubmed search | [1] | [2] | ||||||||||||
|
WikiDoc Resources for Ghrelin | |
|
Articles | |
|---|---|
|
Most recent articles on Ghrelin | |
|
Media | |
|
Evidence Based Medicine | |
|
Clinical Trials | |
|
Ongoing Trials on Ghrelin at Clinical Trials.gov Clinical Trials on Ghrelin at Google
| |
|
Guidelines / Policies / Govt | |
|
US National Guidelines Clearinghouse on Ghrelin
| |
|
Books | |
|
News | |
|
Commentary | |
|
Definitions | |
|
Patient Resources / Community | |
|
Directions to Hospitals Treating Ghrelin Risk calculators and risk factors for Ghrelin
| |
|
Healthcare Provider Resources | |
|
Causes & Risk Factors for Ghrelin | |
|
Continuing Medical Education (CME) | |
|
International | |
|
| |
|
Businness | |
|
Experimental / Informatics | |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [3] Phone:617-525-6884
Please Join in Editing This Page and Apply to be an Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [4] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Ghrelin is a hormone produced mainly by P/D1 cells lining the fundus of the human stomach that stimulate appetite.[1] Ghrelin levels increase before meals and decrease after meals. It is considered the counterpart of the hormone leptin, produced by adipose tissue, which induces satiation when present at higher levels. Ghrelin is also produced in the hypothalamic arcuate nucleus where it stimulates the secretion of growth hormone from the anterior pituitary gland.[1] In some bariatric procedures, the level of ghrelin is reduced in patients, thus causing satiation before it would normally occur.
Receptors for ghrelin are expressed by neurons in the arcuate nucleus and the ventromedial hypothalamus. The ghrelin receptor is a G protein-coupled receptor, formerly known as the GHS receptor (growth hormone secretagogue receptor). Ghrelin is also made by a small population of neurons in the arcuate nucleus. Ghrelin plays a significant role in neurotrophy, particularly in the hippocampus, and is essential for cognitive adaptation to changing environments and the process of learning.[1] Recently, ghrelin has been shown to activate the endothelial isoform of nitric oxide synthase in a pathway that depends on various kinases including Akt.
Forms
Ghrelin exists in an endocrinological inactive (pure peptide) and an active (octanoylated) form (see Hexatropin). Other side chains than octanoyl were also observed.
Mechanism of action
Ghrelin has emerged as the first circulating hunger hormone. Ghrelin and synthetic ghrelin mimetics (the growth hormone secretagogues) increase food intake and increase fat mass[1][1] by an action exerted at the level of the hypothalamus. They activate cells in the arcuate nucleus[1][1] that include the orexigenic neuropeptide Y (NPY) neurones[1]. Ghrelin-responsiveness of these neurones is both leptin and insulin sensitive[1]. Ghrelin also activates the mesolimbic cholinergic-dopaminergic reward link, a circuit that communicates the hedonic and reinforcing aspects of natural rewards, such as food, as well as of addictive drugs, such as ethanol.[1][1] [1]
Role in disease
Ghrelin levels in the plasma of obese individuals are lower than those in leaner individuals. Those suffering from the eating disorder anorexia nervosa appear to have high plasma levels of ghrelin. These findings suggest that ghrelin does not cause anorexia or obesity, rather, ghrelin attempts to correct these disorders. Yildiz and colleagues found that the level of ghrelin increases during the time of day from midnight to dawn in thinner people, suggesting a flaw in the circadian system of obese individuals.[1] Professor Cappuccio of the University of Warwick has recently discovered that short sleep duration may also lead to obesity, through an increase of appetite via hormonal changes. Lack of sleep produces ghrelin, which stimulates appetite and creates less leptin which, amongst its many other effects, suppresses appetite. However, this study does not explain the low levels of Ghrelin found in the obese population. In the fetuses, it seems that ghrelin is early produced by the lung and promotes its growth.[1] Ghrelin levels are also high in patients who have cancer-induced cachexia.[1]
Prader-Willi syndrome is also characterized by high fasting levels of ghrelin; here the ghrelin levels are associated with high food intake.[1]
At least one study found that gastric bypass surgery not only reduces the gut's capacity for food, but also dramatically lowers ghrelin levels.[1]
Animal models indicate that ghrelin may enter the hippocampus from the bloodstream, enhancing learning and memory.[1] It is suggested that learning may be best during the day and when the stomach is empty, since ghrelin levels are higher at these times. In rodents, X/A-like cells produce ghrelin.
Relation to obestatin
Obestatin is a hormone that was found, in late 2005, to decrease appetite. Both obestatin and ghrelin are encoded by the same gene; the gene's product breaks apart to yield the two peptide hormones.[1] The purpose of this mechanism is unknown.
History and name
The discovery of ghrelin was reported by Masayasu Kojima and colleagues in 1999.[1] The name is based on its role as a growth hormone-releasing peptide, with reference to the Proto-Indo-European root ghre, meaning to grow.
Anti-obesity vaccine
Recently Scripps research scientists have developed an anti-obesity vaccine, which is directed against the hormone ghrelin.[1] [1]The vaccine uses the immune system, specifically antibodies, to bind to selected targets, directing the body's own immune response against them. This prevents ghrelin from reaching the central nervous system, thus producing a desired reduction in weight gain.
References
External links
- Gherlin at Colorado State University
- InfoBiogen.fr - 'Ghrelin/MTLRP' (motilin-related peptide)
- NeuroEndo.org.uk - 'Ghrelin: A newly discovered hormone', Dr. Suzanne L. Dickson, University of Cambridge (June 14, 2005)
- ScienceNews.org - 'Still Hungry? Fattening revelations—and new mysteries—about the hunger hormone', Janet Raloff, Science News, vol 167, no 14, p 216 (April 2, 2005)
- Balancing Hunger Hormones - Web site reviewing role of ghrelin and leptin in obesity.
- MeSH ghrelin
de:Ghrelin dv:ޣްރެލިން it:Grelina ja:グレリンuk:Ґрелін
Acknowledgement and Attribution Regarding Sources of Content
Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .
